[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Profit Margin Surge Reinforces Bullish Narratives on Operational Turnaround",
    "summary": "Gilead Sciences (GILD) delivered a net profit margin of 27.9%, a sharp turnaround from just 0.4% a year ago, with earnings growth skyrocketing 6336.5% year over year. Looking ahead, management expects earnings to rise by 9.08% annually and revenue to grow at 4.5% per year, pointing to continued but more tempered expansion. Investors are weighing these strong headline results against prospects for steady future growth and value, especially with the company’s share price sitting below one major...",
    "url": "https://finnhub.io/api/news?id=487942524e5db35b029dd9ff190eefb0b8391b2111f992ab1de9878db1477d32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761956692,
      "headline": "Gilead Sciences (GILD) Profit Margin Surge Reinforces Bullish Narratives on Operational Turnaround",
      "id": 137294809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (GILD) delivered a net profit margin of 27.9%, a sharp turnaround from just 0.4% a year ago, with earnings growth skyrocketing 6336.5% year over year. Looking ahead, management expects earnings to rise by 9.08% annually and revenue to grow at 4.5% per year, pointing to continued but more tempered expansion. Investors are weighing these strong headline results against prospects for steady future growth and value, especially with the company’s share price sitting below one major...",
      "url": "https://finnhub.io/api/news?id=487942524e5db35b029dd9ff190eefb0b8391b2111f992ab1de9878db1477d32"
    }
  }
]